<?xml version="1.0" encoding="UTF-8"?>
<results title="disease">
 <result pre="bold;} span.year {font-family : courier ; font-style : italic;} Eur" exact="Heart" post="J Cardiovasc PharmacotherEur Heart J Cardiovasc PharmacotherehjcvpEuropean Heart Journal"/>
 <result pre="courier ; font-style : italic;} Eur Heart J Cardiovasc PharmacotherEur" exact="Heart" post="J Cardiovasc PharmacotherehjcvpEuropean Heart Journal â€&quot; Cardiovascular Pharmacotherapy2055-68372055-6845Oxford University"/>
 <result pre="italic;} Eur Heart J Cardiovasc PharmacotherEur Heart J Cardiovasc PharmacotherehjcvpEuropean" exact="Heart" post="Journal â€&quot; Cardiovascular Pharmacotherapy2055-68372055-6845Oxford University Press doi: 10.1093/ehjcvp/pvaa042pvaa042 :"/>
 <result pre="University Press doi: 10.1093/ehjcvp/pvaa042pvaa042 : Correspondence Statin therapy in COVID-19" exact="infection" post="http://orcid.org/0000-0002-9285-2328CastiglioneVincenzop1ChiriacÃ²Martinap1p2EmdinMichelep1p3TaddeiStefanop2VergaroGiuseppep1p3[p1], Institute of Life Science, Scuola Superiore Santâ€™AnnaItaly[p2], Department"/>
 <result pre="via PMC and Europe PMC, consistent with existing copyright protections.pvaa042.pdfpage-count:" exact="Severe" post="acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causal"/>
 <result pre="PMC and Europe PMC, consistent with existing copyright protections.pvaa042.pdfpage-count: Severe" exact="acute" post="respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causal agent"/>
 <result pre="and Europe PMC, consistent with existing copyright protections.pvaa042.pdfpage-count: Severe acute" exact="respiratory" post="syndrome coronavirus 2 (SARS-CoV-2) is the causal agent of"/>
 <result pre="Europe PMC, consistent with existing copyright protections.pvaa042.pdfpage-count: Severe acute respiratory" exact="syndrome" post="coronavirus 2 (SARS-CoV-2) is the causal agent of the"/>
 <result pre="is the causal agent of the current pandemic of coronavirus" exact="disease" post="2019 (COVID-19). SARS-CoV-2 is a positive-sense single-stranded RNA betacoronavirus"/>
 <result pre="positive-sense single-stranded RNA betacoronavirus sharing genetic similarities with the severe" exact="acute" post="respiratory syndrome coronavirus 1 (SARS-CoV-1) and the Middle East"/>
 <result pre="single-stranded RNA betacoronavirus sharing genetic similarities with the severe acute" exact="respiratory" post="syndrome coronavirus 1 (SARS-CoV-1) and the Middle East respiratory"/>
 <result pre="RNA betacoronavirus sharing genetic similarities with the severe acute respiratory" exact="syndrome" post="coronavirus 1 (SARS-CoV-1) and the Middle East respiratory syndrome-related"/>
 <result pre="acute respiratory syndrome coronavirus 1 (SARS-CoV-1) and the Middle East" exact="respiratory" post="syndrome-related coronavirus (MERS-CoV).1 SARS-CoV-2 enters the cells mainly through"/>
 <result pre="an intense inflammatory host response, sometimes leading to a life-threatening" exact="acute" post="respiratory distress syndrome (ARDS).1 Several randomized controlled trials (RCTs)"/>
 <result pre="intense inflammatory host response, sometimes leading to a life-threatening acute" exact="respiratory" post="distress syndrome (ARDS).1 Several randomized controlled trials (RCTs) are"/>
 <result pre="host response, sometimes leading to a life-threatening acute respiratory distress" exact="syndrome" post="(ARDS).1 Several randomized controlled trials (RCTs) are investigating the"/>
 <result pre="inflammation and oxidative stress, contributing to their beneficial impact on" exact="cardiovascular" post="diseases. Statins modulate the immune response at different levels,"/>
 <result pre="migration, antigen presentation, and cytokine production. Moreover, they restore the" exact="vascular" post="redox balance by reducing reactive oxygen species and increasing"/>
 <result pre="be beneficial as an add-on therapy in patients with different" exact="autoimmune" post="inflammatory conditions (e.g. systemic lupus erythematosus, rheumatoid arthritis, multiple"/>
 <result pre="add-on therapy in patients with different autoimmune inflammatory conditions (e.g." exact="systemic" post="lupus erythematosus, rheumatoid arthritis, multiple sclerosis, and graft-versus-host disease).2"/>
 <result pre="therapy in patients with different autoimmune inflammatory conditions (e.g. systemic" exact="lupus erythematosus," post="rheumatoid arthritis, multiple sclerosis, and graft-versus-host disease).2 Statins have"/>
 <result pre="patients with different autoimmune inflammatory conditions (e.g. systemic lupus erythematosus," exact="rheumatoid arthritis," post="multiple sclerosis, and graft-versus-host disease).2 Statins have also been"/>
 <result pre="different autoimmune inflammatory conditions (e.g. systemic lupus erythematosus, rheumatoid arthritis," exact="multiple sclerosis," post="and graft-versus-host disease).2 Statins have also been evaluated as"/>
 <result pre="have also been evaluated as an immunomodulatory treatment in various" exact="infectious diseases." post="Although observational studies have reported improved outcomes in patients"/>
 <result pre="observational studies have reported improved outcomes in patients with community-acquired" exact="pneumonia" post="or sepsis receiving statins,3,4 most RCTs on inpatient statin"/>
 <result pre="statins,3,4 most RCTs on inpatient statin treatment in sepsis or" exact="ventilator-associated pneumonia" post="failed to demonstrate a beneficial effect.4 On the other"/>
 <result pre="most RCTs on inpatient statin treatment in sepsis or ventilator-associated" exact="pneumonia" post="failed to demonstrate a beneficial effect.4 On the other"/>
 <result pre="other hand, statin therapy appears promising in the context of" exact="viral" post="infections. Avian influenza viruses induce an intense host response"/>
 <result pre="statin therapy appears promising in the context of viral infections." exact="Avian" post="influenza viruses induce an intense host response characterized by"/>
 <result pre="placebo. An association between outpatient statin use and reduction in" exact="disease" post="severity among patients hospitalized during the 2009 H1N1 pandemic"/>
 <result pre="have therefore advocated statin use as an immunomodulatory therapy for" exact="viral" post="infections with potential for epidemics and pandemics.3 Although no"/>
 <result pre="therefore advocated statin use as an immunomodulatory therapy for viral" exact="infections" post="with potential for epidemics and pandemics.3 Although no RCT"/>
 <result pre="during the recent Ebola outbreak in West Africa.5 Similar to" exact="avian influenza" post="viruses, betacoronaviruses cause severe respiratory illnesses by triggering an"/>
 <result pre="West Africa.5 Similar to avian influenza viruses, betacoronaviruses cause severe" exact="respiratory" post="illnesses by triggering an intense proinflammatory host response. Some"/>
 <result pre="inflammatory pathways.6 Notably, inhibition of NF-ÎºB resulted in reduced lung" exact="infection" post="and increased survival in a murine model of SARS-CoV-1"/>
 <result pre="mechanism of actions and proposed advantages of statins in COVID-19." exact="Severe" post="acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causal agent"/>
 <result pre="of actions and proposed advantages of statins in COVID-19. Severe" exact="acute" post="respiratory syndrome coronavirus 2 (SARS-CoV-2), the causal agent of"/>
 <result pre="actions and proposed advantages of statins in COVID-19. Severe acute" exact="respiratory" post="syndrome coronavirus 2 (SARS-CoV-2), the causal agent of coronavirus"/>
 <result pre="and proposed advantages of statins in COVID-19. Severe acute respiratory" exact="syndrome" post="coronavirus 2 (SARS-CoV-2), the causal agent of coronavirus disease"/>
 <result pre="respiratory syndrome coronavirus 2 (SARS-CoV-2), the causal agent of coronavirus" exact="disease" post="2019 (COVID-19), enters the cell through angiotensin-converting enzyme 2"/>
 <result pre="may prove beneficial in COVID-19 patients. Statins may also counteract" exact="hyperlipidaemia" post="caused by some antiviral and immunosuppressive treatments currently used"/>
 <result pre="SARS-CoV-2 infection. Observational studies have found that elderly people with" exact="cardiovascular" post="comorbidities are more likely to be infected with SARS-CoV-2"/>
 <result pre="develop severe symptoms.1 In addition, there is evidence of direct" exact="cardiovascular" post="involvement in some cases of COVID-19.1 Furthermore, the lipid-lowering"/>
 <result pre="COVID-19.1 Furthermore, the lipid-lowering action of statins could treat the" exact="hyperlipidaemia" post="associated with the use of protease inhibitor-based antiretroviral and"/>
 <result pre="in COVID-19 infection. Statin therapy has proven effective in improving" exact="hyperlipidaemia" post="in patients with human immunodeficiency virus receiving protease inhibitor"/>
 <result pre="has proven effective in improving hyperlipidaemia in patients with human" exact="immunodeficiency" post="virus receiving protease inhibitor treatment10 and in patients with"/>
 <result pre="immunodeficiency virus receiving protease inhibitor treatment10 and in patients with" exact="rheumatoid arthritis" post="receiving tocilizumab (FigureÂ 1).2 Most statins undergo hepatic metabolism"/>
 <result pre="virus receiving protease inhibitor treatment10 and in patients with rheumatoid" exact="arthritis" post="receiving tocilizumab (FigureÂ 1).2 Most statins undergo hepatic metabolism"/>
 <result pre="such as ritonavir and cobicistat, could increase the risk of" exact="muscle" post="and liver toxicity; therefore, starting with a lower dose"/>
 <result pre="risk of muscle and liver toxicity; therefore, starting with a" exact="lower" post="dose of statin and monitoring creatine kinase and transaminases"/>
 <result pre="with COVID-19, either by their immunomodulatory action or by preventing" exact="cardiovascular" post="damage. This hypothesis should warrant consideration for phase III"/>
 <result pre="References 1MadjidM, Safavi-NaeiniP, SolomonSD, VardenyO.Potential effects of coronaviruses on the" exact="cardiovascular" post="system: a review. JAMA Cardiol2020;doi: 10.1001/jamacardio.2020.1286. 2ZeiserR.Immune modulatory effects"/>
 <result pre="TRIF contributes to a protective innate immune response to severe" exact="acute" post="respiratory syndrome coronavirus infection. mBio2015;6:e00638-15.26015500 7DeDiegoML, Nieto-TorresJL, Regla-NavaJA, Jimenez-GuardenoJM,"/>
 <result pre="contributes to a protective innate immune response to severe acute" exact="respiratory" post="syndrome coronavirus infection. mBio2015;6:e00638-15.26015500 7DeDiegoML, Nieto-TorresJL, Regla-NavaJA, Jimenez-GuardenoJM, Fernandez-DelgadoR,"/>
 <result pre="to a protective innate immune response to severe acute respiratory" exact="syndrome" post="coronavirus infection. mBio2015;6:e00638-15.26015500 7DeDiegoML, Nieto-TorresJL, Regla-NavaJA, Jimenez-GuardenoJM, Fernandez-DelgadoR, FettC,"/>
 <result pre="Fernandez-DelgadoR, FettC, CastaÃ±o-RodriguezC, PerlmanS, EnjuanesL.Inhibition of NF-ÎºB-mediated inflammation in severe" exact="acute" post="respiratory syndrome coronavirus-infected mice increases survival. J Virol2014;88:913â€&quot;24.24198408 8YuanX,"/>
 <result pre="FettC, CastaÃ±o-RodriguezC, PerlmanS, EnjuanesL.Inhibition of NF-ÎºB-mediated inflammation in severe acute" exact="respiratory" post="syndrome coronavirus-infected mice increases survival. J Virol2014;88:913â€&quot;24.24198408 8YuanX, DengY,"/>
 <result pre="CastaÃ±o-RodriguezC, PerlmanS, EnjuanesL.Inhibition of NF-ÎºB-mediated inflammation in severe acute respiratory" exact="syndrome" post="coronavirus-infected mice increases survival. J Virol2014;88:913â€&quot;24.24198408 8YuanX, DengY, GuoX,"/>
 <result pre="DengY, GuoX, ShangJ, ZhuD, LiuH.Atorvastatin attenuates myocardial remodeling induced by" exact="chronic" post="intermittent hypoxia in rats: partly involvement of TLR-4/MYD88 pathway."/>
 <result pre="ShangJ, ZhuD, LiuH.Atorvastatin attenuates myocardial remodeling induced by chronic intermittent" exact="hypoxia" post="in rats: partly involvement of TLR-4/MYD88 pathway. Biochem Biophys"/>
 <result pre="Allergy2009;27:49â€&quot;57. 10EckardAR, McComseyGA.The role of statins in the setting of" exact="HIV infection." post="Curr HIV-AIDS Rep2015;12:305â€&quot;312."/>
</results>
